Related references
Note: Only part of the references are listed.Activated KRAS Cooperates with MLL-AF4 to Promote Extramedullary Engraftment and Migration of Cord Blood CD34+ HSPC But Is Insufficient to Initiate Leukemia
Cristina Prieto et al.
CANCER RESEARCH (2016)
The IRX1/HOXA connection: insights into a novel t(4;11)-specific cancer mechanism
Alessa Kuehn et al.
ONCOTARGET (2016)
Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia
Alejandra Sanjuan-Pla et al.
BLOOD (2015)
Subclonality and prenatal origin of RAS mutations in KMT2A (MLL)-rearranged infant acute lymphoblastic leukaemia
Mariana Emerenciano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias
Anna K. Andersson et al.
NATURE GENETICS (2015)
The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias
Vincent-Philippe Lavallee et al.
NATURE GENETICS (2015)
Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement
M. Bardini et al.
LEUKEMIA (2015)
MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road
Christopher J. Caunt et al.
NATURE REVIEWS CANCER (2015)
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2014)
Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover
Xin Hong et al.
EMBO JOURNAL (2014)
Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma
Weiying Zhang et al.
SCIENCE SIGNALING (2014)
Low PKCα expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcome
Gloria Milani et al.
ONCOTARGET (2014)
Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain
Simona Soverini et al.
BLOOD (2013)
Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia
Shilpa Gandre-Babbe et al.
BLOOD (2013)
The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia
Sara E. Dobbins et al.
GENES CHROMOSOMES & CANCER (2013)
Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants
Emma M. C. Driessen et al.
HAEMATOLOGICA (2013)
Robustness of Amplicon Deep Sequencing Underlines Its Utility in Clinical Applications
Vera Grossmann et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Jinghui Zhang et al.
NATURE (2012)
Performance comparison of benchtop high-throughput sequencing platforms
Nicholas J. Loman et al.
NATURE BIOTECHNOLOGY (2012)
Reliable detection of subclonal single-nucleotide variants in tumour cell populations
Moritz Gerstung et al.
NATURE COMMUNICATIONS (2012)
Mechanisms of leukemogenesis by MLL fusion proteins
Rolf Marschalek
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients
M. Bardini et al.
LEUKEMIA (2011)
The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories
A. Kohlmann et al.
LEUKEMIA (2011)
Activated K-Ras protein accelerates human MLL/AF4-induced leukemo-lymphomogenicity in a transgenic mouse model
H. Tamai et al.
LEUKEMIA (2011)
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing
Sonia Melo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cytoscape Web: an interactive web-based network browser
Christian T. Lopes et al.
BIOINFORMATICS (2010)
Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants
Ronald W. Stam et al.
BLOOD (2010)
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study
Georg Mann et al.
BLOOD (2010)
The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4
Adelheid Bursen et al.
BLOOD (2010)
Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group
Torsten Haferlach et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
MEK Inhibitor PD0325901 Significantly Reduces the Growth of Papillary Thyroid Carcinoma Cells In vitro and In vivo
Ying C. Henderson et al.
MOLECULAR CANCER THERAPEUTICS (2010)
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4
M. Bardini et al.
LEUKEMIA (2010)
APPLICATIONS OF NEXT-GENERATION SEQUENCING Sequencing technologies - the next generation
Michael L. Metzker
NATURE REVIEWS GENETICS (2010)
Overcoming bias and systematic errors in next generation sequencing data
Margaret A. Taub et al.
GENOME MEDICINE (2010)
Two independent gene signatures in pediatric t(4;11) acute lymphoblastic leukemia patients
Luca Trentin et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias
Andrei V. Krivtsov et al.
CANCER CELL (2008)
Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia
Marian Case et al.
CANCER RESEARCH (2008)
MLL translocations, histone modifications and leukaemia stem-cell development
Andrei V. Krivtsov et al.
NATURE REVIEWS CANCER (2007)
Clinical experience of MEK inhibitors in cancer therapy
Ding Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Adjusting batch effects in microarray expression data using empirical Bayes methods
W. Evan Johnson et al.
BIOSTATISTICS (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy
Weili Chen et al.
BLOOD (2006)
A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology
M. Metzler et al.
ONCOGENE (2006)
K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements
DC Liang et al.
CANCER (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia
RW Stam et al.
BLOOD (2005)
Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis
R Ono et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements
CH Pui et al.
LEUKEMIA (2003)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Inhibition of FLT3 in MLL: Validation of a therapeutic target identified by gene expression based classification
SA Armstrong et al.
CANCER CELL (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins
PM Ayton et al.
ONCOGENE (2001)
Share Paper
